A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation. Implications of arrhythmia progression on prognosis: The Belgrade atrial fibrillation study

Chest

Volumn 141, Issue 2, 2012, Pages 339-347

  Potpara, Tatjana S ^a,b   Stankovic, Goran R ^a,b   Beleslin, Branko D ^a,b   Polovina, Marija M ^a   Marinkovic, Jelena M ^b   Ostojic, Miodrag C ^a,b   Lip, Gregory Y H ^c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; FLECAINIDE; PROPAFENONE; QUINIDINE SULFATE; SOTALOL; VERAPAMIL;

ADULT; AGE; AGED; ARTICLE; CARDIOVERSION; CHADS2 SCORE; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; HATCH SCORE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; HYPERTENSION; LONE ATRIAL FIBRILLATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; SCORING SYSTEM; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; VALIDATION STUDY;

EID: 83755160879     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-0340     Document Type: Article

References (36)

1. Ryder MK, Benjamin JE. Epidemiology and significance of atrial fibrillation. Am J Cardiol. 1999;84(suppl 1):131-138.
2. Lloyd-Jones DM, Wang TJ, Leip EP, Benjamin EJ. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110(9):1042-1046. (Pubitemid 39319000)
3. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol.1994;74(3):236-241. (Pubitemid 24239044)
4. Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Circulation. 2006;114(7):700-752. (Pubitemid 44252312)
5. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med. 1987;317(11):669-674. (Pubitemid 17138192)
6. Chugh SS, Blackshear JL, Shen WK, Hammil SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001;37(2):371-378.
7. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946-952. (Pubitemid 28446646)
8. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint infl uence on mortality: the Framingham Heart Study. Circulation. 2003;107(23):2920-2925. (Pubitemid 36736633)
9. Savelieva I, Camm AJ. Atrial fibrillation and heart failure: natural history and pharmacological treatment. Europace.2004;5(suppl 1):S5-S19. (Pubitemid 39193160)
10. Jahangir A, Lee V, Friedman PA, et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation. A 30-year follow-up study. Circulation. 2007;115(24):3050-3056. (Pubitemid 46956493)
11. Scardi S, Mazzone C, Pandullo C, Goldstein D, Poletti A, Humar F. Lone atrial fibrillation: prognostic differences between paroxysmal and chronic forms after 10 years of follow-up. Am Heart J. 1999;137(4 pt 1):686-691. (Pubitemid 29173583)
12. Gersh BJ, Solomon A. Lone atrial fibrillation: epidemiology and natural history. Am Heart J. 1999;137(4 pt 1):592-595. (Pubitemid 29173568)
13. Rostagno C, Bacci F, Martelli M, Naldoni A, Bertini G, Gensini G. Clinical course of lone atrial fibrillation since first symptomatic arrhythmic episode. Am J Cardiol. 1995;76(11):837-839.
14. Osranek M, Bursi F, Bailey KR, Naldoni A, Bertini G, Gensini G. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Eur Heart J. 2005;26(23):2556-2561. (Pubitemid 41679360)
15. Brand FN, Abbot RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham study. JAMA. 1985;254(24):3449-3453. (Pubitemid 16148410)
16. de Vos CB, Pisters R, Nieuwlaat R, et al. Progression from paroxysmal to persistent atrial fibrillation. J Am Coll Cardiol.2010;55(8):725-731.
17. Davidson E, Rotenberg Z, Weinberger I, Fuchs J, Agmon J. Diagnosis and characteristics of lone atrial fibrillation. Chest.1989;95(5):1048-1050. (Pubitemid 19136998)
18. Potpara TS, Lip GYH. Lone atrial fibrillation: what is known and what is to come? Int J Clin Pract. 2011;65(4):446-457.
19. Kopecky SL, Gersh BJ, McGoon MD, et al. Lone atrial fibrillation in elderly persons. A marker for cardiovascular risk. Arch Intern Med. 1999;159(10):1118-1122. (Pubitemid 29230865)
20. Schoonderwoerd BA, Smit MD, Pen L, Van Gelder IC. New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'. Europace. 2008;10(6):668-673. (Pubitemid 351775282)
21. Al-Khatib SM, Wilkinson WE, Sanders L, McCarthy EA, Pritchett ELC. Observation on the transition from intermittent to permanent atrial fibrillation. Am Heart J. 2000;140(1):142-145. (Pubitemid 30471254)
22. Frustaci A, Chimenti C, Belloci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96(4):1180-1184. (Pubitemid 27344221)
23. Skalidis EI, Hamilos MI, Karalis IK, Chlouverakis G, Kochiadakis GE, Vardas PE. Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation. J Am Coll Cardiol. 2008;51(21):2053-2057. (Pubitemid 351680520)
24. Kourliouros A, Savelieva I, Kiotsekoglou A, Jahangiri M, Camm J. Current concepts in the pathogenesis of atrial fibrillation . Am Heart J. 2009;157(2):243-252.
25. Jaïs P, Hocini M, MacLe L, et al. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation. 2002;106(19):2479-2485. (Pubitemid 35278805)
26. Van Gelder IC, Hemels MEW. The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm. Europace. 2006;8(11):943-949. (Pubitemid 44644158)
27. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002;54(2):230-246. (Pubitemid 34327903)
28. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery; Camm JA, Kirchof P, Lip GYH, et al. Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(10):2369-2429.
29. Wang TS, Massaro JM, Levy D, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community. The Framingham Heart Study. JAMA. 2003;290(8):1049-1056. (Pubitemid 37430445)
30. Lip GYH, Nieuwlaat R, Pisters R, Lane D, Crijns H. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: the Euro Heart Survey on Atrial Fibrillation. Chest.2010;137(2):263-272.
31. Nieuwlaat R, Capucci A, Lip GYH, et al Euro Heart Survey Investigators. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2006;27(24):3018-3026. (Pubitemid 44963431)
32. Van Staa TP, Setakis E, Di Tanna GL, Lane DA, Lip GY. A comparison of risk stratification schemes for stroke in 79884 atrial fibrillation patients in general practice. J Thromb Haemost. 2011;9(1):39-48.
33. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet.2009;373(9658):155-166.
34. Miyasaka Y, Barnes ME, Gersh BJ, et al. Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades. Eur Heart J.2006;27(8):936-941.
35. Jouven X, Desnos M, Guerot C, Ducimetiere P. Idiopathic atrial fibrillation as a risk factor for mortality. The Paris Prospective Study I. Eur Heart J. 1999;20(12):896-899. (Pubitemid 29253736)
36. Potpara T, Grujić M, Marinković J, Vujisić- Tesić B, Ostojić M, Polovina M. Mortality of patients with lone and idiopathic atrial fibrillation is similar to mortality in general population of Serbia. Vojnosanit Pregl. 2010;67(2):132-135.